Search - tctmd.com

Displaying 441 - 460 of 585

Sort: Relevancy | Date

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

Presentation TCT 2012

Pharmacotherapy for Acute Coronary Syndromes/NSTEMI

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Presenter: George Dangas

October 22, 2012

Presentation TCT 2012

Acute Coronary Syndromes: STEMI

Presenter: Michael Kim

October 21, 2012

Presentation TCT 2012

Acute Coronary Syndromes: NSTEMI

Presenter: Duane Pinto

October 21, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Caitlin E. Cox

September 20, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

September 18, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

News Daily News

SCAAR Data Support Obesity Paradox: Overweight ACS Patients Show Lower Mortality

Jason Kahn

September 11, 2012

News Daily News

Los Datos del SCAAR Avalan la Paradoja de la Obesidad: Los Pacientes con Sobrepeso que sufren un SCA tienen Menos Riesgo de Mortalidad

Jason Kahn

September 11, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Caitlin E. Cox

August 24, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

Advertisement

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

Pharmacotherapy for Acute Coronary Syndromes/NSTEMI

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Acute Coronary Syndromes: STEMI

Acute Coronary Syndromes: NSTEMI

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

Early Invasive Strategy in NSTEMI Patients Improves Survival

SCAAR Data Support Obesity Paradox: Overweight ACS Patients Show Lower Mortality

Los Datos del SCAAR Avalan la Paradoja de la Obesidad: Los Pacientes con Sobrepeso que sufren un SCA tienen Menos Riesgo de Mortalidad

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content